-Thus, increasing the volume of distribution will increase the half life
-A word about bioequivalence. For two drugs to be bioequivalent, they need to have the same bioavailability and the same rate of absorption. Plasma levels should be the same if given (a) at the same dose and (b) by the same mode PHARMACODYNAMICS -Affinity: ability of a drug to bind to its receptor, shown by proximity of curve to Y axis
-Potency: Shows relative doses of 2 or more agonists to produce the same magnitide of effect. Also shown by proximity to the Y axis provided that the D/R curves are the same
-Efficacy: Measure of how well a drug produces a response. Shown by maximum height of the dose respnse curve.
-Full agonists produce maximal efficacy
-Partial agonists are capable of eliciting a maximal response and are less effective than full agonists
-Just like allosteric enzymes, dose response curves provide information about antagonism and agonism
-In a sigmoidal D/R cuve with % response on Y axis on Log dose of drug on the X axis, potentiators will shift the D/R curve to the left
-Like carbon monoxide binding to HgB, an agonist will shift the curve to the left. Like 2-3 BPG, any inhibitor (antagonist) will right shift the curve
-Thus, competitive antagonists cause a parallel shift to the right
-Quantal dose response curve: plot percentage of a populaion responding to a specified drug effect versus dose or log dose
-Quantal curves reveal the range of intersubject variability in drug response
-The therapeutic interval is simply the TD50/ED50 or LD50/ED50. Low therapeutic indices are less than 2 SIGNALING MECHANISMS:
-Intracellular receptors are for steroids. Binding of hormones to receptors releases regulatory proteins that permit dimerization
-These complexes interact with response elements on nuclear DNA to modify gene expression
-Intracellular receptors exist for thyroid hormones, gonadal steroids, and vitamin D
ION CHANNELS
-Many drugs mimick or antagonize the action of endogenous ligands that regulate the flow of ions through excitable membranes via activation of receptors that are directly coupled to ion channels
-The nicotine receptor for Ach, the skeletal myoneural junction, and the CNS is coupled to an Na/K ion channel
-Receptor is a target for many drugs including nicotine, chiline esters, ganglion blockers and skeletal muscle relaxants
-GABA receptors are coupled to a chloride ion channel
CYCLIC GMP
-cGMP is a second messenger in vascular smooth muscle that facilitates dephosphorylation of myosin light chains, preventing interaction with actin and causing vasodilaton